Jim Simons's position in Rocket Pharmaceuticals is currently worth $1.52 Million. That's 0.00% of their equity portfolio (2020th largest holding). The first Rocket Pharmaceuticals trade was made in Q1 2018. Since then Jim Simons bought shares ten more times and sold shares on eleven occasions. The stake costed the investor $1.35 Million, netting the investor a gain of 13% so far.